SCHEMBL25919939

SCHEMBL25919939

CSCCCCCCNCCN(C)C(=O)NC(C)(C)C(C)=O

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.37
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919936 1.00 PAOX (0.37) PAOXALDH1A1
SCHEMBL25896237 0.99 PAOX (0.35) PAOXALDH1A1
SCHEMBL10330544 0.82
SCHEMBL26616375 0.78 PAOX (0.32) PAOX
SCHEMBL25825777 0.76 EPHX1 (0.42) PAOXALDH1A1
SCHEMBL20026472 0.76 EPHX1 (0.42) PAOXALDH1A1
SCHEMBL26972905 0.76 PAOX (0.31) PAOX
SCHEMBL20026584 0.74 EPHX1 (0.40) PAOXALDH1A1
SCHEMBL22353370 0.73 PRMT3 (0.37)
SCHEMBL25920340 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218722-A1 PTH Compounds with Low Peak-To-Trough Ratios ASCENDIS PHARMA BONE DISEASES AS (DK) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218722-A1 PTH Compounds with Low Peak-To-Trough Ratios PTH1R, PTMS, FGF23 PAOX 3905/4885ALDH1A1 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.